July 23, 2026 01:28 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'We won't leave Jantar Mantar until Dharmendra Pradhan resigns': CJP draws red line | 'Don't waste our time': Supreme Court snubs plea on NEET protest crackdown | Trump's 200% tariff bomb on generic drugs: Here's how India could be hit | Rahul Gandhi, Priyanka Gandhi Vadra lead Congress march to PM Modi's residence over student protest crackdown | 'We can't ignore his concerns': Delhi HC gives Sonam Wangchuk big relief, clears shift to private hospital | 'Students are being tortured': Mamata Banerjee offers to join CJP protest in Delhi | Sikkim tunnel horror: 8 dead, several feared trapped after NHPC project collapse | As NEET protests intensify, PM Modi defends govt action, calls for 'foolproof' education system | After NEET storm, Modi govt faces fresh challenge as farmers march to Delhi over India-US trade deal | Jantar Mantar reclaimed! CJP defies overnight police eviction, returns to protest site

GlaxoSmithKline records 8% growth

| | Aug 07, 2014, at 04:03 am
New Delhi, Aug 6 (IBNS): GlaxoSmithKline Consumer Healthcare Limited on Wednesday declared its financial results for the first quarter ended June 30, 2014, where it recorded its net sales at Rs 922 crores, making a growth of 8% over 2013 with PAT at Rs. 130 crores growing by 9% for the same period and PBT at Rs 198 crores growing by 9%.
Commenting on the results, Zubair Ahmed, Managing Director, GlaxoSmithKline Consumer Healthcare Limited said, “We are proud to deliver consistent growth ahead of the category. This is significant in a scenario where consumption pattern is being impacted by inflation. Our sciences based products with its superior value, continue to remain relevant for our large consumer base."
 
"As a market leader we are also growing the category with successful launches of new products which are driving up consumption experiences. Our focused access strategy ensures that consumption and penetration has been the enabler for growth. Customer driven innovations and clutter breaking marketing based on sharp consumer insights will continue to be our driving force in the coming months to bring in more consumers closer to the product," he said.
 
The company also noted that in a recent addition to the Board of Directors, Sangeeta Talwar has been appointed as an Independent Director in casual vacancy created by the resignation of Ireena Vittal. 
 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.